Literature DB >> 8308776

Sex ratio in the spondyloarthropathies and its relationship to phenotypic expression, mode of inheritance and age at onset.

L G Kennedy1, R Will, A Calin.   

Abstract

OBJECTIVE: To investigate the interrelated effect of phenotypic expression [i.e., primary ankylosing spondylitis (1 degree AS) or disease secondary to psoriasis (Ps) AS or inflammatory bowel disease (IBD)AS], age at onset, sex and inheritance of responsible genes in AS.
METHODS: Three studies were performed to evaluate 1949 subjects with AS. Subgroups of the patients were formed for each study depending on disease type (1 degree AS = 1695; Ps AS = 173; IBD AS = 81), nature of inheritance or age at onset of AS symptoms. These groups were further subdivided to assess the effect of sex.
RESULTS: The sex ratio of the entire group was 2.6:1 in favor of men. However, IBD AS had an equal sex distribution as does IBD alone. By contrast, Ps, which has an equal sex ratio as a lone event or in association with arthritis, resulted in a male dominance of 4.1:1 when it occurred as Ps AS. Women with IBD AS had a significantly younger onset compared to women with 1 degree AS [mean onset 21.7 years (SD 6.65) vs mean onset 24.4 years (SD 9.79), respectively; p = 0.019]. A younger age at onset was found in women with familial disease [mean 22.2 years (SD 7.55)] compared with the mean onset of sporadic disease in women [24.5 years (SD 10.0); p = 0.0059]. There was a progressive fall in the sex ratio as the age at onset increased (p = 0.053). For example: M:F ratio of < 20 years old was 3:1 compared to 1.8:1 for those with an onset of > 40 years.
CONCLUSION: Sex ratio and age at onset are influenced both by each other and such factors as disease type and familial versus sporadic occurrence. These data help provide a predictable pattern of disease in spondyloarthropathy.

Entities:  

Mesh:

Year:  1993        PMID: 8308776

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

1.  Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study.

Authors:  P Trontzas; A Andrianakos; S Miyakis; K Pantelidou; E Vafiadou; V Garantziotou; C Voudouris
Journal:  Clin Rheumatol       Date:  2005-04-29       Impact factor: 2.980

2.  Profile of ankylosing spondylitis in Saudi Arabia.

Authors:  A al-Arfaj
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

3.  Comparison of rates of referral and diagnosis of axial spondyloarthritis before and after an ankylosing spondylitis public awareness campaign.

Authors:  Andrew A Harrison; Christoffel Badenhorst; Sandra Kirby; Douglas White; Josie Athens; Simon Stebbings
Journal:  Clin Rheumatol       Date:  2014-03-11       Impact factor: 2.980

4.  Gender characterization in a large series of Brazilian patients with spondyloarthritis.

Authors:  Hellen M S de Carvalho; Adriana B Bortoluzzo; Célio R Gonçalves; José Antonio Braga da Silva; Antonio Carlos Ximenes; Manoel B Bértolo; Sandra L E Ribeiro; Mauro Keiserman; Rita Menin; Thelma L Skare; Sueli Carneiro; Valderílio F Azevedo; Walber P Vieira; Elisa N Albuquerque; Washington A Bianchi; Rubens Bonfiglioli; Cristiano Campanholo; Izaias P Costa; Angela P Duarte; Maria Bernadete O Gavi; Charles L Kohem; Nocy H Leite; Sonia A L Lima; Eduardo S Meirelles; Ivânio A Pereira; Marcelo M Pinheiro; Elizandra Polito; Gustavo G Resende; Francisco Airton C Rocha; Mittermayer B Santiago; Maria de Fátima L C Sauma; Percival D Sampaio-Barros
Journal:  Clin Rheumatol       Date:  2011-12-28       Impact factor: 2.980

5.  Gender and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2011-07-28       Impact factor: 2.980

6.  Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity.

Authors:  Anatoly V Rubtsov; Kira Rubtsova; Aryeh Fischer; Richard T Meehan; Joann Z Gillis; John W Kappler; Philippa Marrack
Journal:  Blood       Date:  2011-05-04       Impact factor: 22.113

Review 7.  Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.

Authors:  Wonuk Lee; John D Reveille; John C Davis; Thomas J Learch; Michael M Ward; Michael H Weisman
Journal:  Ann Rheum Dis       Date:  2006-11-24       Impact factor: 19.103

8.  The disease burden of axial spondyloarthritis: through a gendered lens.

Authors:  Sara Khan; Divya Shridharmurthy; Kate L Lapane; Catherine Dube; Jonathan Kay; Esther Yi; Shao-Hsien Liu
Journal:  Clin Rheumatol       Date:  2022-01-06       Impact factor: 2.980

9.  Impact of gender, work, and clinical presentation on diagnostic delay in Italian patients with primary ankylosing spondylitis.

Authors:  F Bandinelli; G Salvadorini; A Delle Sedie; L Riente; S Bombardieri; M Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2015-08-04       Impact factor: 2.980

10.  Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS).

Authors:  Marco Garrido-Cumbrera; Denis Poddubnyy; Laure Gossec; Raj Mahapatra; Christine Bundy; Souzi Makri; Sergio Sanz-Gómez; Laura Christen; Carlos J Delgado-Domínguez; Victoria Navarro-Compán
Journal:  Clin Rheumatol       Date:  2021-01-19       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.